Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis

Blood (2021) 138 (3): 273–282.

https://doi.org/10.1182/blood.2021011281

Published: 2021

Journal Articles

Estimating the Need for Complex Malignant Hematologists in Ontario Using Monte Carlo Simulation

Jonathan Wang, MASc, Andre C. Schuh, MD FRCPC, Deanna Wu, MBA, Christopher N. Bredeson, MD MSc, FRCPC, Jacinta Meharchand, MD FRCPC, Lisa Favell, MBA, Louis Fu, MISt, Kelly J. Woltman, MA, C. Tom Kouroukis, MDMSc,FRCPC

Blood (2017) 130 (Supplement 1): 3397.

https://doi.org/10.1182/blood.V130.Suppl_1.3397.3397

Published: 2017

Journal Articles

Bendamustine and Rituximab Versus Conventional Chemoimmunotherapy As a Frontline Treatment for Patients with Indolent B-Cell Lymphoma: A Cost-Effectiveness Analysis

Andrew Aw, MD MEng, FRCPC, Kathryn Coyle, BScPharm, MSc, Isabelle Bence-Bruckler, MD FRCPC, Christopher N. Bredeson, MD MSc, FRCPC, Doug Coyle, MA, MSc, PhD

Blood (2016) 128 (22): 1186.

https://doi.org/10.1182/blood.V128.22.1186.1186

Published: 2016

Journal Articles

Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant

Adam Bryant, MD, Ranjeeta Mallick, Lothar B. Huebsch, MD, David S. Allan, MD FRCPC, Harold Atkins, MDFRCPC, Grizel Anstee, MD, Isabelle Bence-Bruckler, MD FRCPC, Linda Hamelin, Michael Hodgins, MD, Mitchell Sabloff, MDM, Nicholas Scrivens, Dawn C. Maze, MDFRCPC,MSc, Christopher N. Bredeson, MD MSc, FRCPC, Natasha Kekre, MDMPH, FRCPC

Blood (2016) 128 (22): 5782.

https://doi.org/10.1182/blood.V128.22.5782.5782

Published: 2016

Journal Articles

Factors Influencing Long-Term Hematopoietic Function Following Autologous Stem Cell Transplantation

Alissa Visram, MD, Natasha Kekre, MD MPH, FRCPC, Christopher N. Bredeson, MD MSc, FRCPC, Jason Tay, MDFRCPC MSc, Lothar B. Huebsch, MD, Sheryl McDiarmid, Ranjeeta Mallick, PhD, Mitchell Sabloff, MDM, Harold Atkins, MDFRCPC, David S. Allan, MD FRCPC, Alan Tinmouth, MD FRCPC, Linda Hamelin, Lisa Martin, Dawn Maze, MD FRCPC MSc

Blood (2016) 128 (22): 2186.

https://doi.org/10.1182/blood.V128.22.2186.2186

Published: 2016

Journal Articles

Comparison of Total Body Irradiation-Based with Intravenous Busulfan-Based Chemotherapy-Only Conditioning Regimens for Myeloablative Hematopoietic Cell Transplantation (HCT) in Adults with Acute Lymphoblastic Leukemia

Blood (2016) 128 (22): 679.

https://doi.org/10.1182/blood.V128.22.679.679

Published: 2016

Journal Articles

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Blood (2014) 124 (21): 209.

https://doi.org/10.1182/blood.V124.21.209.209

Published: 2014

Journal Articles

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

Blood (2012) 120 (20): 4256–4262.

https://doi.org/10.1182/blood-2012-06-436725

Published: 2012

Includes: Supplemental data

Journal Articles

HLA-matched sibling bone marrow transplantation for β-thalassemia major

Mitchell Sabloff, Mammen Chandy, Zhiwei Wang, Brent R. Logan, Ardeshir Ghavamzadeh, Chi-Kong Li, Syed Mohammad Irfan, Christopher N. Bredeson, Morton J. Cowan, Robert Peter Gale, Gregory A. Hale, John Horan, Suradej Hongeng, Mary Eapen, Mark C. Walters

Blood (2011) 117 (5): 1745–1750.

https://doi.org/10.1182/blood-2010-09-306829

Published: 2011

Journal Articles

Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study

Philippe Armand, MD, PhD, Waleska Perez, MPH, Mei-Jie Zhang, PhD, Haesook Kim, PhD, Thomas R. Klumpp, MD, Paola Dal Cin, PhD, Edmund K Waller, MD, PhD, Mark R. Litzow, MD, Jane L. Liesveld, MD, Hillard M. Lazarus, MD, FACP, Andrew Artz, MD, MS, Vikas Gupta, MD, MRCP, FRCPath, Bipin N. Savani, MD, Philip L. McCarthy, MD, Jean-Yves Cahn, MD, Harry Schouten, Jurgen Finke, MD, Edward D. Ball, MD, Mahmoud Aljurf, MD, Corey Cutler, MD, MPH, FRCPC, Jacob M. Rowe, Joseph H. Antin, MD, Luis M Isola, MD, Paolo Di Bartolomeo, MD, Bruce Camitta, MD, Alan M Miller, MD, PhD, Mitchell S. Cairo, MD, Keith E. Stockerl-Goldstein, MD, Jorge Sierra, MD, Mary Lynn Savoie, MD, FRCPC, Joerg Halter, MD, Patrick J Stiff, MD, Chadi Nabhan, MD, FACP, Ann A. Jakubowski, MD, PhD, Donald Bunjes, MD, Effie W. Petersdorf, MD, Steven M Devine, MD, Richard Maziarz, MD, Martin Bornhauser, MD, Victor A Lewis, MD, David I. Marks, MBBS, PHD, Christopher N Bredeson, MD, MSc, FRCPC, Robert Soiffer, MD, Daniel J. Weisdorf, MD

Blood (2010) 116 (21): 680.

https://doi.org/10.1182/blood.V116.21.680.680

Published: 2010

Journal Articles

Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission

Blood (2008) 112 (2): 426–434.

https://doi.org/10.1182/blood-2007-12-128918

Published: 2008

Journal Articles

Comparable Outcomes in Secretory (SM) Versus Non-Secretory (NSM) Multiple Myeloma (MM) with Autologous Hematopoietic Stem Cell Transplantation (AuHCT).

Shaji Kumar, MD, Waleska S. Pérez, MPH, Mei-Jie Zhang, PhD, Christopher N. Bredeson, MD, MSc, Martha Q. Lacy, MD, Gustavo Milone, MD, Donna Reece, MD, David H. Vesole, MD, PhD, Parameswaran Hari, MD

Blood (2007) 110 (11): 944.

https://doi.org/10.1182/blood.V110.11.944.944

Published: 2007

Journal Articles

Biologic Assignment Clinical Trials in Hematopoietic Stem Cell Transplantation (HSCT) for Multiple Myeloma: Baseline Characteristics by Treatment Allocation from BMT CTN 0102 According to Availability of an HLA-Matched Sibling Donor.

Marcelo C. Pasquini, MD, MS, Marian Ewell, PhD, Edward A. Stadtmauer, MD, Christopher N. Bredeson, MD, MSc, FRCPC, Edwin P. Alyea, MD, Keith Stockerl-Goldstein, MD, Amrita Krishnan, MD, Firoozeh Sahebi, MD, Scott D. Rowley, MD, David G. Maloney, MD, David H. Vesole, MD, PhD, Mary M. Horowitz, MD, MS, Shelly Carter, PhD, Nancy Geller, PhD, Sergio Giralt, MD, Blood Marrow Transplant Clinical Trials Network (BMT CTN)

Blood (2007) 110 (11): 3028.

https://doi.org/10.1182/blood.V110.11.3028.3028

Published: 2007

Journal Articles

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

Hubert Schrezenmeier, Jakob R. Passweg, Judith C. W. Marsh, Andrea Bacigalupo, Christopher N. Bredeson, Eduardo Bullorsky, Bruce M. Camitta, Richard E. Champlin, Robert Peter Gale, Monika Fuhrer, John P. Klein, Anna Locasciulli, Rosi Oneto, Antonius V. M. B. Schattenberg, Gerard Socie, Mary Eapen

Blood (2007) 110 (4): 1397–1400.

https://doi.org/10.1182/blood-2007-03-081596

Published: 2007

Journal Articles

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

Richard E. Champlin, Waleska S. Perez, Jakob R. Passweg, John P. Klein, Bruce M. Camitta, Eliane Gluckman, Christopher N. Bredeson, Mary Eapen, Mary M. Horowitz

Blood (2007) 109 (10): 4582–4585.

https://doi.org/10.1182/blood-2006-10-052308

Published: 2007

Journal Articles

Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States

Fausto R. Loberiza, Jr, Mei-Jie Zhang, Stephanie J. Lee, John P. Klein, Charles F. LeMaistre, Derek S. Serna, Mary Eapen, Christopher N. Bredeson, Mary M. Horowitz, J. Douglas Rizzo

Blood (2005) 105 (7): 2979–2987.

https://doi.org/10.1182/blood-2004-10-3863

Published: 2005

Journal Articles

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry

Blood (2004) 104 (12): 3797–3803.

https://doi.org/10.1182/blood-2004-01-0231

Published: 2004

Journal Articles

Prevalence of Microbially Contaminated Hematopoietic Stem Cell Products.

Richard E. Champlin, MD, Fausto R. Loberiza, Jr., MD, MS, Mary Eapen, MD, MS, J. Douglas Rizzo, MD, Christopher N. Bredeson, MD, MSc, John E. Wagner, MD, Mary M. Horowitz, MD, MS, on behalf of the Histocompatibility Alternative Stem Cell Sources Working Committee of the Center for International Blood Marrow Transplant Research (CIBMTR)

Blood (2004) 104 (11): 2228.

https://doi.org/10.1182/blood.V104.11.2228.2228

Published: 2004

Journal Articles

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia

Jorge Sierra, Waleska S. Pérez, Ciril Rozman, Enric Carreras, John P. Klein, J. Douglas Rizzo, Stella M. Davies, Hillard M. Lazarus, Christopher N. Bredeson, David I. Marks, Carmen Canals, Marc A. Boogaerts, John Goldman, Richard E. Champlin, Armand Keating, Daniel J. Weisdorf, Theo M. de Witte, Mary M. Horowitz

Blood (2002) 100 (6): 1997–2004.

https://doi.org/10.1182/blood.V100.6.1997

Published: 2002

NARROW

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis

Estimating the Need for Complex Malignant Hematologists in Ontario Using Monte Carlo Simulation

Bendamustine and Rituximab Versus Conventional Chemoimmunotherapy As a Frontline Treatment for Patients with Indolent B-Cell Lymphoma: A Cost-Effectiveness Analysis

Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant

Factors Influencing Long-Term Hematopoietic Function Following Autologous Stem Cell Transplantation

Comparison of Total Body Irradiation-Based with Intravenous Busulfan-Based Chemotherapy-Only Conditioning Regimens for Myeloablative Hematopoietic Cell Transplantation (HCT) in Adults with Acute Lymphoblastic Leukemia

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

HLA-matched sibling bone marrow transplantation for β-thalassemia major

Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study

Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission

Comparable Outcomes in Secretory (SM) Versus Non-Secretory (NSM) Multiple Myeloma (MM) with Autologous Hematopoietic Stem Cell Transplantation (AuHCT).

Biologic Assignment Clinical Trials in Hematopoietic Stem Cell Transplantation (HSCT) for Multiple Myeloma: Baseline Characteristics by Treatment Allocation from BMT CTN 0102 According to Availability of an HLA-Matched Sibling Donor.

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry

Prevalence of Microbially Contaminated Hematopoietic Stem Cell Products.

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only